Evidence map›Paper›PMID 31042467›Full record

ArticleCell reports2019

Identification of a Locus in Mice that Regulates the Collateral Damage and Lethality of Virus Infection.

Ichiro Misumi, Kevin D Cook, Joseph E Mitchell, Makayla M Lund, Sarah C Vick, Robert H Lee, Toru Uchimura, Wolfgang Bergmeier, Piotr Mieczkowski, Fernando Pardo-Manuel de Villena and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ichiro MisumiDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Kevin D CookDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Joseph E MitchellDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Makayla M LundDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Sarah C VickDepartment of Microbiology and Immunology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Robert H LeeDepartment of Biochemistry/Biophysics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Toru UchimuraDepartment of Microbiology and Immunology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Wolfgang BergmeierDepartment of Biochemistry/Biophysics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Piotr MieczkowskiDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Fernando Pardo-Manuel de VillenaDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Jenny P Y TingDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA.
Jason K WhitmireDepartment of Genetics, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, UNC-Chapel Hill School of Medicine, Chapel Hill, NC 27599, USA. Electronic address: jwhitmir@email.unc.edu.
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina Health Care · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Resource Section - Core 001U42OD010924 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TERRY R MAGNUSON · 2012 to 2026
$24.5M
Proteomics Pathway DiscoveryU19AI109965 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2014 to 2018
$14.9M
Research Training in Hematology at UNC Chapel HillT32HL007149 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Nigel S. Key · 1985 to 2026
$8.6M
Molecular and Functional Analysis of NLR Family MembersR01AI029564 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jenny P Ting · 1991 to 2026
$6.0M
Regulation of CD8+ T cell responses to chronic virus infectionR01AI143894 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2019 to 2023
$2.5M
Obesity associated viral pathogenesisR01AI138337 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2018 to 2022
$1.9M
Rap1 signaling in platelet homeostasis and vascular hemostasisR01HL130404 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BERGMEIER, WOLFGANG · 2016 to 2018
$1.2M
Genetic and mechanistic dissection of a lethal systemic virus infectionR21AI117575 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2015 to 2016
$418k
NK cell regulation of adaptive immunity during persisting virus infectionR56AI110682 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WHITMIRE, JASON KYLE · 2014 to 2014
$380k
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL130404NHLBI NIH HHS T32 HL007149NIAID NIH HHS R01 AI029564NIAID NIH HHS R01 AI138337NIAID NIH HHS R01 AI143894NIAID NIH HHS R21 AI117575NIAID NIH HHS R56 AI110682NIAID NIH HHS U19 AI109965NIH HHS U42 OD010924
6 · The paper itself

Abstract

Arenaviruses can cause severe hemorrhagic disease in humans, which can progress to organ failure and death. The underlying mechanisms causing lethality and person-to-person variation in outcome remain incompletely explained. Herein, we characterize a mouse model that recapitulates many features of pathogenesis observed in humans with arenavirus-induced hemorrhagic disease, including thrombocytopenia, severe vascular leakage, lung edema, and lethality. The susceptibility of congenic B6.PL mice to lymphocytic choriomeningitis virus (LCMV) infection is associated with increased antiviral T cell responses in B6.PL mice compared with C57BL/6 mice and is T cell dependent. Pathogenesis imparted by the causative locus is inherited in a semi-dominant manner in F1 crosses. The locus includes PL-derived sequence variants in both poorly annotated genes and genes known to contribute to immune responses. This model can be used to further interrogate how limited genetic differences in the host can remarkably alter the disease course of viral infection.

Indexed as

Genetic LociAnimalsCell LineCells, CulturedChlorocebus aethiopsChromosomesCricetinaeFemaleGenetic Predisposition to DiseaseLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMaleMiceMice, Inbred C57BLMultiple Organ FailureVero CellsarenavirusCD8(+) T cellsforward genetic mappingLCMVmouse geneticsthrombocytopeniaviral hemorrhagic diseaseviral pathogenesis

Identifiers

PMID31042467
PMCPMC6508094
OpenAlexW2943800550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.